Option Care Health, Inc. key statistics and ratios
In fiscal 2025, Option Care Health, Inc. had return on equity of 15.2% and a net margin of 3.7%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2007Dec 2007 | 2008Dec 2008 | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net margin | 0.3% | −5.3% | 4.1% | −4.2% | 0.4% | −4.6% | 0.2% | −0.3% | −3.3% | −0.3% | 4.1% | 3.8% | 6.2% | 4.2% | 3.7% | 3.7% |
| Return on equity | 2.0% | −56.6% | 43.1% | −38.9% | 3.8% | −10.5% | 0.6% | −1.0% | −10.1% | −0.8% | 12.8% | 11.8% | 19.0% | 15.0% | 15.2% | 16.2% |
| Return on assets | — | −30.0% | 20.3% | −14.5% | 1.2% | −6.7% | 0.6% | −0.6% | −3.8% | −0.3% | 5.1% | 5.1% | 8.4% | 6.4% | 6.0% | 6.1% |
| Effective tax rate | 40.6% | — | — | — | — | — | — | — | — | — | −20.1% | 26.8% | 25.5% | 25.3% | 26.6% | 26.6% |
| SG&A as % of revenue | — | — | — | — | — | — | 18.5% | 17.8% | 19.9% | 16.5% | 15.3% | 14.4% | 14.1% | 12.6% | 12.1% | 12.0% |
Financial health
- Short-term assets cover short-term liabilities $1.2bn of assets due within a year against $819m of liabilities due within a year.
- Short-term assets cover long-term liabilities $1.2bn short-term assets against $1.3bn of longer-dated liabilities.
- More cash than debt $194m of cash against $1.2bn of debt.
- Debt below 40% of shareholders' equity Debt is 92% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 90% to 92% over five years.
- A year's operating cash flow covers at least 20% of debt $347m of operating cash flow against $1.2bn of debt.
- Operating profit covers interest at least five times over Operating income of $334m against $54m of interest.
Moat
Moderate moat
How hard Option Care Health's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 12 / 20
Cash operating profit has been a median 9.6% of total assets over 7 years.
- Pricing power 7 / 20
Gross margin has been a median 22.0%, moving by 3.5 percentage points (standard deviation) across 10 years.
- Durability 3 / 20
Operating margin has been a median 5.4%; its worst year was 0.9%.
- Cash conversion 11 / 20
Free cash flow was positive in 8 of 9 years, at a median 4.4% of revenue.
- Discipline 20 / 20
The diluted share count fell 13.3% over five years; stock-based pay has been a median 0.3% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (52 before it).
Compare with peers
- Agilon Health, Inc. statistics
- Astrana Health, Inc. statistics
- AMN Healthcare Services Inc statistics
- Quest Diagnostics statistics
- Chemed Corp statistics
Head to head: AGL vs OPCHASTH vs OPCHAMN vs OPCH
More: Health Care Services stocks compared, Health Care sector, rankings of US companies